APA (7th ed.) Citation

Z, L., A, P., F, B., C, D., L, L., N, M., . . . I, D. (2025). Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants. NPJ vaccines, 10(1), 75. https://doi.org/10.1038/s41541-025-01123-y

Chicago Style (17th ed.) Citation

Z, Lakhrif, et al. "Intranasal Spike and Nucleoprotein Fusion Protein-based Vaccine Provides Cross-protection and Reduced Transmission Against SARS-CoV-2 Variants." NPJ Vaccines 10, no. 1 (2025): 75. https://doi.org/10.1038/s41541-025-01123-y.

MLA (9th ed.) Citation

Z, Lakhrif, et al. "Intranasal Spike and Nucleoprotein Fusion Protein-based Vaccine Provides Cross-protection and Reduced Transmission Against SARS-CoV-2 Variants." NPJ Vaccines, vol. 10, no. 1, 2025, p. 75, https://doi.org/10.1038/s41541-025-01123-y.